National and Kapodistrian University of Athens
Ο ρόλος των υπερήχων και της μαγνητικής τομογραφίας στη μελέτη των καρδιακών εκδηλώσεων του αντιφωσφολιπιδικού συνδρόμου
Abstract
dc:descriptionAntiphospholipid syndrome (APS) is an acquired immune-mediated thrombophilia characterized by recurrent arterial and/or venous thromboses and/or pregnancy morbidity in the presence of antiphospholipid antibodies. The spectrum of clinical manifestations attributed to APS also include cardiac disease, renal thrombotic microangiopathy, livedo reticularis, hemolytic anemia and central nervous system manifestations. The pathophysiology, clinical and laboratory findings of the commonest cardiac manifestations in APS (valvulopathy, coronary artery disease, myocardial dysfunction and pulmonary hypertension) are described in the first section of the thesis. The second section deals with the evolution of valve involvement and myocardial dysfunction over time in patients with systemic lupuserythematosus (SLE) with or without antiphospholipid antibodies (aPL) and/or APS. Seventeen patients with primary APS (PAPS), 23 with SLE-associated APS (SLE/APS), 19 with SLE positive for aPL without APS, and 23 with SLE negative for aPL had been assessed by transthoracic echocardiography 10 years ago and were re-evaluated in the present study. Valvulopathy was detected in 65% of PAPS and 62% of SLE patients with or without aPL. Disease duration [odds ratio (OR), 1.63; 95% confidence interval (CI), 1.13–2.36; p=0.009 for every 5 years of increase] and presence of SLE/APS (OR, 3.51; 95% CI, 1.27–9.67; p=0.015) were the only factors associated with the progression of valvular disease in univariate and multivariate analyses. Left ventricular diastolic dysfunction similarly progressed over time, with deceleration time (DT) and isovolumic relaxation time (IVRT) being equally prolonged in each of the four groups (p<0.05). Right ventricular DT was significantly prolonged in each of the three SLE patient groups (p<0.001), whereas IVRT increased only in SLE/APS patients (p=0.040). In conclusion, among patients with APS and SLE (with or without aPL), SLE/APS and disease duration were independent factors for valvular disease progression in the present 10-year follow-up echocardiography study. Anticoagulation did not arrest valvular disease progression. Ventricular diastolic dysfunction, primarily of the left ventricle, also progressed over the 10-year period.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kampolis, Christos
- Καμπόλης, Χρήστος
Subjects
dc:subject × 12Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39602